A.R.T. Advisors’s MiMedx Group MDXG Stock Holding History

A.R.T. Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-141,414	Closed	-$903K	–	1570
2018 Q2	$903K	Sell	141,414 -76,109	-35%	-$542K	0.04%	677
2018 Q1	$1.52M	Buy	217,523 +167,376	+334%	+$1.95M	0.06%	504
2017 Q4	$632K	Buy	+50,147	New	+$612K	0.03%	799
2015 Q1	–	Sell	-142,808	Closed	-$1.65M	–	1581
2014 Q4	$1.65M	Buy	142,808 +101,726	+248%	+$1M	0.06%	446
2014 Q3	$292K	Buy	+41,082	New	+$286K	0.01%	946

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

A.R.T. Advisors's MDXG Position: Q3 2018 in Review

A.R.T. Advisors sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 141,414 shares — an estimated $903K sold.

A.R.T. Advisors first reported a position in MDXG in Q3 2014 and held it in 5 quarters. The position peaked at $1.65M in Q4 2014. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

A.R.T. Advisors reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
A.R.T. Advisors sold 141,414 MiMedx Group shares in Q3 2018, an estimated $903K.
A.R.T. Advisors first reported a position in MiMedx Group in Q3 2014 and held it in 5 quarters.
A.R.T. Advisors's MiMedx Group position peaked at $1.65M in Q4 2014.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on A.R.T. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.